Introduction
Type 2 diabetes mellitus is a major health problem worldwide. In Egypt, type 2 diabetes is a major health issue. Th e current prevalence of diabetes in Egypt is among the world's 10 highest countries. Th e expected number of individuals with diabetes in Egypt (20-79 age groups) will be 8.6 million in 2030 [1] [2] [3] . Type 2 diabetes is characterized by peripheral insulin resistance with an insulin-secretory defect that varies in severity. Insulin resistance in the off spring of patients with type 2 diabetes has been known to be the best predictor of the development of the disease [4] .
Vascular complications are the main cause of morbidity and mortality in diabetes mellitus. Hyperglycemia, obesity, hypertension, dyslipidemia, and insulin resistance are factors that contribute toward the development of diabetic vascular complications [5] . Diabetes mellitus and subsequent microvascular and macrovascular complications occur as a result of interactions between environmental factors and genetic susceptibility [4, 6] .
Th e LMNA gene is located on chromosome 1q 21, a susceptibility locus for type 2 diabetes. Mutations in the LMNA gene, which encodes the nuclear structural proteins lamins A and C, cause one form of familial partial lipodystrophy, a monogenic syndrome of extreme insulin resistance, abnormal fat distribution, dyslipidemia, hypertension, diabetes, and vascular complications [7, 8] . Th e LMNA 1908 C/T polymorphism is the most common LMNA single nucleotide polymorphism (SNP) that encodes a silent mutation that alters the relative amounts of lamins A and C. It has been shown to be associated with dyslipidemia as it is considered to be a high risk factor for atherosclerosis and vascular disease; thus, LMNA 1908 C/T SNP might play a role in susceptibility to diabetic vascular complications [5] .
Materials and methods
Th is was a prospective study carried out over a period of 1 year and included 47 type 2 diabetes patients with diabetic vascular complications who were attending the Internal Medicine Clinics, Diabetes Clinic, and Internal Medicine Hospital of Kasr El Aini Hospital, Faculty of Medicine, Cairo University, and 20 healthy control participants.
All patients and control groups were subjected to the following:
(1) Full assessment of history including age of onset of diabetes, duration of diabetes, and complications.
(2) Th orough clinical examination, general, cardiac, neurological, and fundus examination, and calculation of BMI.
Laboratory investigations: fasting blood glucose (mg/dl), serum lipid profi le including total cholesterol, triglycerides, HDL-cholesterol, LDL-cholesterol (mg/dl), fasting serum insulin level (μU/ml), calculation of insulin resistance by homeostasis model assessment (HOMA-IR) as fasting insulin concentration (μU/ml)×fasting glucose concentration (mg/dl)/405 [9] , urinary albumin excretion (mg/24 h), and genomic DNA extraction, and analysis of the LMNA 1908 C/T gene polymorphism using PCR, followed by restriction fragment length polymorphism analysis.
Exclusion criteria
Patients with nondiabetic renal disease, microscopic hematuria, clinical pyuria, or evidence of bacterial infection in urine culture were excluded; also in addition, patients with apparent cardioembolic cerebral infarction or an undetermined subtype of infarction were excluded. Th e protocol of this study was approved by the review board of the department of Internal Medicine according to the Declaration of Helsinki.
Statistical methods
Th e SPSS 10.0 for windows (SPSS Inc., Chicago, Illinois, USA) was used for data management and analysis. Quantitative data were presented as mean ±SD. For comparison of the means of both groups, Student's t-test was used. Th e association between qualitative data was assessed us ing the χ 2 -test. Risk estimate was carried out by odds ratio (OR). A P value was considered signifi cant at 0.05.
Results
A total of 47 patients and 20 healthy controls were enrolled. Th e patient group included 20 men and 27 women (ranging age between 35 and 67 years), whereas the control group included 11 men and nine women (ranging in age between 32 and 63 years).
Th e BMI and the laboratory parameters among the studied groups are compared in Table 1 , which showed statistical signifi canc e for fasting blood sugar (FBS ), total cholesterol, LDL-C, triglycerides, HOMA, and microalbumin urea in diabetic patients in comparison with the control group.
Th e number of patients and percentages of diff erent vascular complications in group I (diabetic patients) were as follows: diabetic nephropathy (DN) (N = 17) (36.2%), retinopathy (N = 16) (34%), neuropathy (14) (29.8%), coronary heart disease (CHD) (N = 10) (21.3%), and cerebrovascular disease (CVD) (N = 8) (17%).
Allele frequency and risk ratio of the LMNA 1908 C/T allele between cases and controls are shown in Table  2 , which showed statistical signifi cance in the diabetic group in the allele mutation in comparison with the control group (P = 0.031).
The LMNA 1908 C/T genotype frequency and risk ratio in cases and controls are shown in Table 3 . Table 4 shows a comparison of the clinical features and laboratory parameters among the diabetic group according to the LMNA 1908 C/T genotype.
Th e LMNA 1908 C/T genotype frequency and risk ratio in cases with nephropathy , CVD , CHD, retinopathy, and neuropathy are shown in Tables 5 and 6 . The data are represented as mean ± SD or median (25th-75th percentile); FBG, fasting blood glucose; HDL-C, HDL-cholesterol; HOMA, homeostasis model assessment; LDL-C, LDL-cholesterol. Carriers of the LMNA 1908 T-allele showed a signifi cantly higher prevalence of DN than carriers of the C-allele (P < 0.05). Multiple regression analysis showed that the LMNA 1908 T-allele tended to be an independent risk factor for DN (P = 0.012, OR = 5.460).
Discussion
Type 2 diabetes is a major global health problem that aff ects over 170 million individuals worldwide; it will be certainly one of the major diseases of the 21st century and should be recognized as a priority [4] .
Th e genetic component in the pathogenesis of type 2 diabetes and development of vascular complications is very signifi cant, but has been shown to be complex, as single gene disorders are only seldom responsible. Patterns of inheritance suggest that type 2 diabetes is both polygenic and heterogeneous as multiple genes are involved and diff erent combinations of genes play a role in diff erent subsets of individuals [4] .
One of these contributor genes is the LMNA gene; the most common genetic variant in the LMNA gene is the C to T substitution at position 1908 in exon 10.
Although it is a silent mutation, it could alte r mRNA splicing and thus the relative amount of lamins A and C mRNA and related proteins [5] . Confl icting results have been reported on the association of LMNA SNPs and diabetes mellitus, some of which suggest modest positive associations, whereas others did not report any convincing association [10] . Th e aim of this study, therefore, was to investigate the association between the LMNA 1908 C/T polymorphism and the prevalence of vascular complications in a group of Egyptian patients with type 2 diabetes.
Th is study included two groups: group I included 47 type 2 diabetic patients with vascular complications; there were 20 men (42.6%) and 27 women (57.4%) ranging in age from 35 to 67 years (52.9+8.9). Group II included 20 healthy adult volunteers as a control group: 11 men (55%) and nine women (45%) ranging in age from 32 to 63 years (43.9+10.6).
According to the type of macrovascular or microvascular complications, group I included 17 patients with DN (36.2%), 16 patients with retinopathy (34%), 14 patients with neuropathy (29.8%), 10 patients with CHD (21.3%), and eight patients with CVD (17%).
Th e mean age of patients recruited in this study with the wild genotype (CC) was 49.5+10.4 years, whereas the mean age of patients with the mutant genotype (CT and TT) was 51.6+10.1 years. Th is was in agreement with the study by Liang et al. [5] who reported a mean age of 56 (46-62) and 54 (44-63) years for patients with wild and mutant genotypes, respectively.
Comparison of the clinical features and laboratory parameters of the study participants according to the LMNA 1908 C/T genotype indicated a statistically signifi cant increase in fasting plasma glucose levels in carriers of the T-allele than carriers of the C-allele (P = 0.004). Th is fi nding was in agreement with that of Wegner et al. [11] who reported, in a Danish cohort study, that the T-allele was associated with increased fasting glucose concentration (P = 0.008). Also, fasting insulin and HOMA-IR showed a statistically signifi cant increase in carriers of the T-allele than carriers of the C-allele, with P-values of 0.00 and 0.00, respectively, which indicates that the LMNA 1908 C/T SNP may play a role in hyperinsulinemia and development of insulin resistance in type 2 diabetes patients. Th ese fi ndings were not in agreement with those of Murase et al. [12] who reported, in a Japanese study, that LMNA 1908 C/T SNP was a factor predisposing to insulin resistance (P = 0.01); also, Mukti et al. [13] reported that this gene variant is associated with insulin resistance and generalized obesity in Indians.
In the present study, 24 h urinary microalbumin was signifi cantly increased in patients with the T-allele than those with the C-allele (P = 0.01), which indicates that LMNA C/T 1908 SNP may lead to the risk of developing nephropathy in type 2 diabetic patients.
Th is study found no statistically signifi cant diff erence in BMI between carriers of the T-allele and the C-allele (P = 0.065), and this result was in agreement with Wolford et al. [14] in a Pima Indian study and Liang et al. [5] in a Japanese study. Th is result is not in agreement with the study by Hegele et al. [15] who reported that carriers o f LMNA 1908 C/T SNP had higher BMI and indices of obesity. Th e discrepancy between the previous observations may be because of linkage disequilibrium of the 1908 T SNP with other ethnicity-specifi c polymorphisms.
In the current study, genomic DNA analysis of the LMNA 1908 gene showed that the frequency of the wild genotype (CC) was 57.4 and 85%, whereas that of the mutant genotype (CT and TT) was 42.6 and 15% in the patient and control groups, respectively. Th is indicated a statistically signifi cant increase in the frequency of the mutant genotype in the diabetic patients compared with the control participants [OR = 4.19, 95% confi dence interval (CI) = 1.081-16.302, P = 0.048]. Th is result was in agreement with the study by Wegner et al. [11] (P = 0.04).
In this study, the frequency of the T-allele was 23.4 and 7.5%, whereas that of the C-allele was 76.6 and 92.5% for cases and controls, respectively; there was a statistically signifi cant increase in the mutant allele in cases compared with the control participants, with P = 0.031, OR = 3.76, and 95% CI = 1.059-13.41. When subgroup analysis of type 2 diabetic patients was stratifi ed according to their vascular complications, it was found that carriers of the mutant genotype (CT and TT) were more prevalent in diabetic patients with nephropathy than those with the wild genotype (CC) (OR = 4.27, 95% CI = 1.20-15.15, P = 0.021). Also, the frequency of the T-allele was 38.3 and 15%, whereas the frequency of the C-allele was 61.7 and 85% in diabetic patients with nephropathy and those without nephropathy, respectively (P = 0.011); on estimating the risk ratio of the mutant allele, the OR was 3.508 and 95% CI was 1.303-9.443.
Th ese results indicate that type 2 diabetic patients harboring the LMNA 1908 T-allele showed a higher risk for development of DN than those harboring the C-allele. Th ese fi ndings are in agreement with those of Liang and colleagues, who carried out their study on Japanese participants and reported that the frequencies of LMNA 1908 C/T and TT genotypes were 65.7 and 45%, whereas the frequencies of the of CC genotype were 34.3 and 55% in patients with DN and those without DN, respectively (P = 0.036); they also reported that the frequency of the T-allele was 38.6 and 24%, whereas that of the C-allele was 61.4 and 76% in patients with DN and those without DN, respectively (P = 0.022) [5] .
Th is study did not fi nd an association between 1908 C/T SNP and development of CVD in type 2 diabetic patients (P = 0.258); this was in contrast to the result reported by Liang et al. [5] , who found an association between this SNP and development of CVD in type 2 diabetes patients (0.003). Th is may be attributed to the relatively smaller number of participants included in the present study.
Th e present study found no association between 1908 C/T SNP and development of CHD, retinopathy, or neuropathy in type 2 diabetes patients (P = 0.481, 0.615, 0.978, respectively). Th ese results were in agreement with those of Liang et al. [5] . By applying a logistic regression analysis for risk factors for DN on the data of the present study, it was found that the LMNA T genotype is an independent risk factor for development of DN, with OR = 5.460, 95% CI = 1.464-20.366, and P = 0.012. Th is is in agreement with the study by Liang et al. [5] , who found a signifi cant correlation between the LMNA 1908 T-allele and DN (OR = 2.97, 95% CI = 0.89-9.94, and P = 0.047).
In conclusion, these results suggest that the LMNA 1908 C/T SNP is associated with the development of DN in Egyptian type 2 diabetic patients.
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